Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
CHICAGO, Jan. 27, 2017 -- A recent study found that Varium™, the natural growth promoter for poultry from Amlan International, performed better than antibiotics alone, delivering significant reductions in mortality, and improvements in feed conversion and intestinal health, for a 10:1 return on investment.
“As the reduction or elimination of antibiotics in broiler production continues to expand worldwide, Varium is proving to be an effective way to enhance the growth-promoting abilities of antibiotics, or, when used in antibiotic-free production, to achieve bird performance equivalent to flocks receiving sub-therapeutic levels of antibiotics,” said Dr. Ron Cravens, President of Amlan International, a Nevada Corporation.
“We’re very pleased our customers’ broilers receiving Varium experienced improved villi height and a reduction in crypt depth indicating improved intestinal integrity,” said Cravens. “It’s quite notable that an improved European Efficiency Index (EEI) score was also seen, increasing from 350 to 400 points.”
Compared to the control diet that included antibiotics, feeding Varium decreased mortality by 40%, from 6.93% to 4.18%, with improvements seen throughout the growout period, not just in young birds. Feed conversion improved 15 points, from 1.64 to 1.49, with the majority of the gains seen after day 7 and a greater response seen in female broilers.
Varium is a registered product in a variety of countries, including China and Mexico. For a full list of registered countries and a complete study of the results and more information on Varium, please visit Amlan.com. Varium is sold outside the U.S.
About Amlan International
Oil-Dri Corporation of America (NYSE:ODC), doing business as Amlan International, helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2013, the company’s global reach expanded with the establishment of its China subsidiary in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.
Media Contact Mike McPherson 312.706.3379 [email protected] www.amlan.com
